Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P16104 (
H2AX
)
3,930
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Formation of gamma-
H2AX
foci is a P. O.cellular response to genotoxic stress, such as DNA double strand breaks or stalled replication forks. Here we show that gamma-
H2AX
foci were also formed when cells were incubated with 0.5 microg/ml DNA intercalating agent actinomycin D. In untreated cells, gamma-
H2AX
co-immunoprecipitated with Ku70, a subunit of DNA-dependent protein kinase, as well as with nuclear DNA helicase II (NDH II), a DEXH family helicase also known as RNA helicase A or
DHX9
. This association was increased manifold after actinomycin D treatment. DNA degradation diminished the amount of Ku70 associated with gamma-
H2AX
but not that of NDH II. In vitro binding studies with recombinant NDH II and
H2AX
phosphorylated by DNA-dependent protein kinase confirmed a direct physical interaction between NDH II and gamma-
H2AX
. Thereby, the NDH II DEXH domain alone, i.e. its catalytic core, was able to support binding to gamma-
H2AX
. Congruently, after actinomycin D treatment, NDH II accumulated in RNA-containing nuclear bodies that predominantly co-localized with gamma-
H2AX
foci. Taken together, these results suggest that histone gamma-
H2AX
promotes binding of NDH II to transcriptionally stalled sites on chromosomal DNA.
...
PMID:Actinomycin D induces histone gamma-H2AX foci and complex formation of gamma-H2AX with Ku70 and nuclear DNA helicase II. 1561 78